|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, JD |
Date | 7/20/2018 11:30:36 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY 2018 Omnibus Appropriations, provisions relating to funding for gun violence research
FY 2019 Labor-HHS Appropriations, provisions relating to funding for gun violence research
FY 2019 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, provisions relating to FDA oversight of tobacco products
FY 2019 House and Senate Appropriations bills, provisions relating to funding for NIH, National Diabetes Prevention Program, community health centers, National Health Services Corps, and Teaching Health Center Graduate Medical Education programs
Bipartisan Budget Act of 2018, provisions related to Telehealth
Consolidated Appropriations Act of 2018, provisions related to Conrad 30 reauthorization
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Jason |
Marino |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 4508, Promoting Real Opportunity, Success, and Prosperity through Education Reform (PROSPER) Act, all provisions
Higher Education Act Reauthorization
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 394, Restoring Access to Medication Act of 2017, all provisions
S. 85, Restoring Access to Medication Act of 2017, all provisions
S. 2456, CARA 2.0 Act of 2018, all provisions
S. 2680, Opioid Crisis Response Act of 2018, all provisions
S. 2535, Opioid Quota Reform Act, all provisions
H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, all provisions
S. 3120, Helping to End Addiction and Lessen Substance Use Disorders Act of 2018, all provisions
S. 2891, Fighting the Opioid Epidemic with Sunshine Act of 2018, all provisions
S. 3042, Agriculture Improvement Act of 2018, provisions related to the SNAP Program
H.R. 5818, Opioid Workforce Act of 2018, all provisions
S. 2843, Opioid Workforce Act of 2018, all provisions
H.R. 3692, Addiction Treatment Access Improvement Act of 2017, all provisions
H.R. 5812, Creating Opportunities that Necessitate New and Enhanced Connections That Improve Opioid Navigation Strategies (CONNECTIONS) Act of 2018, all provisions
H.R. 5002, Advancing Cutting Edge (ACE) Research Act, all provisions
S. 2406, Advancing Cutting Edge (ACE) Research Act, all provisions
H.Amdt.627 to H.R. 2, provisions relating to unpasteurized milk or milk products
H.R. 449, Synthetic Drug Awareness Act of 2018, all provisions
H.R. 4275, Empowering Pharmacists in the Fight Against Opioid Abuse Act, all provisions
H.R. 4284, Indexing Narcotics, Fentanyl, and Opioids (INFO) Act of 2018, all provisions
H.R. 5041, Safe Disposal of Unused Medication Act, all provisions
H.R. 5202, Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018, all provisions
H.R. 5102, Substance Use Disorder Workforce Loan Repayment Act of 2018, all provisions
S. 2524, Substance Use Disorder Workforce Loan Repayment Act of 2018, all provisions
H.R. 5176, Preventing Overdoses While in Emergency Rooms Act of 2018, all provisions
H.R. 5197, Alternatives to Opioids (ALTO) in the Emergency Department Act, all provisions
H.R. 5261, Treatment, Education, and Community Help (TEACH) to Combat Addiction Act of 2018, all provisions
H.R. 5272, Reinforcing Evidence-Based Standards Under Law in Treating Substance Abuse (RESULTS) Act of 2018, all provisions
H.R. 5327, Comprehensive Opioid Recovery Centers Act of 2018, all provisions
H.R. 5329, Poison Center Network Enhancement Act of 2018, all provisions
H.R. 5483, Special Registration for Telemedicine Clarification Act of 2018, all provisions
H.R. 5580, Surveillance and Testing of Opioids to Prevent (STOP) Fentanyl Deaths Act of 2018, all provisions
H.R. 5687, Securing Opioids and Unused Narcotics with Deliberate (SOUND) Disposal and Packaging Act of 2018, all provisions
H.R. 5353, Eliminating Opioid Related Infectious Diseases Act of 2018, all provisions
H.R. 5796, Responsible Education Achieves Care and Healthy Outcomes for Users' Treatment (REACH OUT) Act of 2018, all provisions
H.R. 1375, Prescriber Support Act of 2017, all provisions
H.R. 5788, Synthetics Trafficking and Overdose Prevention (STOP) Act of 2018, all provisions
H.R. 1057, Synthetics Trafficking and Overdose Prevention (STOP) Act of 2017, all provisions
H.R. 6142, Reducing Drug Waste Act of 2018, all provisions
H.R. 4909, Student, Teachers, and Officers Preventing (STOP) School Violence Act of 2018, all provisions
H.R. 4477, Fix NICS Act of 2017, all provisions
S. 2135, Fix NICS Act of 2017, all provisions
H.R. 4240, Public Safety and Second Amendment Rights Protection Act of 2017, all provisions
S. 2456, CARA 2.0 Act of 2018, all provisions
S. 1803, Marijuana Effective Drug Studies Act of 2017, all provisions
S. 1112, Maternal Health Accountability Act of 2017, all provisions
Affordable Care Act stability
42 CFR Part 2/Substance abuse confidentiality regulations
Substance Use Disorder
Prescription Drug Monitoring Program (PDMP)
Federal prescription limits
Health Savings Accounts - Prescription requirement for over-the-counter medications
Sunshine Act Regulations - journal reprints and textbooks
Drug pricing transparency
Augmented Intelligence (AI)
Laboratory testing oversight
Laboratory Developed Tests
Software as a medical device
Drug compounding
Breastfeeding
Patient Matching
Mortality
Cybersecurity
Transparency in regulatory science
Regulatory burdens
Gun violence research
Bump stocks
Physician Assisted Suicide
AMA/Google Health Care Interoperability and Innovation Challenge
Health insurance premiums
Title X funding
Virtual Diabetes Prevention Program (DPP)/Telehealth/remote patient monitoring
Electronic prescribing of controlled substances
Pharmacy Benefits Manager
HHS Blueprint to lower drug prices
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Centers For Disease Control & Prevention (CDC), Environmental Protection Agency (EPA), Justice - Dept of (DOJ), Drug Enforcement Administration (DEA), Homeland Security - Dept of (DHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matthew |
Reid |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Ashley |
McGlone |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 392, Fairness for High-Skilled Immigrants Act of 2017, all provisions
S. 898, Conrad State 30 and Physician Access Reauthorization Act, all provisions
H-1B Visa/wage data
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Citizenship & Immigration Services (USCIS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
Margaret |
Garikes |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
CVS-Aetna Merger
Competition in healthcare markets
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 3331, To amend title XI of the Social Security Act to promote testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology, all provisions
S. 1732, Improving Access to Behavioral Health Information Technology Act, all provisions
S. 2904, Medicaid Substance Use Disorder Treatment via Telehealth Act, all provisions
S. 2910, Telehealth for Children's Access to Services and Treatment (TeleCAST) Act, all provisions
S. 2707, Informing Seniors about Opioids Act of 2018, all provisions
S. 2900, Comprehensive Screenings for Seniors Act of 201, all provisions
H.R. 3528, Every Prescription Conveyed Securely Act, all provisions
S. 2460, Every Prescription Conveyed Securely Act, all provisions
S. 2908, A bill to amend title XVIII of the Social Security Act to provide for electronic prior authorization under Medicare part D for covered part D drugs, and for other purposes, all provisions
S. 2920, Commit to Opioid Medical Prescriber Accountability and Safety for Seniors Act of 2018, all provisions
H.R. 4552, Advancing Medical Resident Training in Community Hospitals Act of 2017, all provisions
S. 1291, Advancing Medical Resident Training in Community Hospitals Act of 2017, all provisions
H.R. 284, Advancing Medical Resident Training in Community Hospitals Act of 2017, all provisions
H.R. 5605, Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act, all provisions
H.R. 5801, Medicaid Providers Are Required To Note Experiences in Record Systems to Help In-need Patients (PARTNERSHIP) Act, all provisions
H.R. 5797, Individuals in Medicaid Deserve Care that is Appropriate and Responsible in its Execution (IMD CARE) Act, all provisions
H.R. 5800, Medicaid Institutes for Mental Disease Are Decisive in Delivering Inpatient Treatment for Individuals but Opportunities for Needed Access are Limited without Information Needed about Facility Obligations (IMD ADDITIONAL INFO) Act, all provisions
H.R. 5799, Medicaid Drug Review, Utilization, Good Governance (DRUG) Improvement Act, all provisions
H.R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018, all provisions
H.R. 5603, Access to Telehealth Services for Substance Use Disorders Act, all provisions
H.R. 5808, Medicaid Pharmaceutical Home Act of 2018, all provisions
H.R. 5685, Medicare Opioid Safety Education Act of 2018, all provisions
H.R. 5675, To amend title XVIII of the Social Security Act to require prescription drug plan sponsors under the Medicare program to establish drug management programs for at-risk beneficiaries, all provisions
H.R. 1925, At-Risk Youth Medicaid Protection Act of 2018, all provisions
H.R. 3192, CHIP Mental Health Parity Act, all provisions
H.R. 4005, Medicaid Reentry Act, all provisions
H.R. 4998, Health Insurance for Former Foster Youth Act, all provisions
H.R. 5477, Rural Development of Opioid Capacity Services (DOCS) Act, all provisions
H.R. 5582, Abuse Deterrent Access Act of 2018, all provisions
H.R. 5583, To amend title XI of the Social Security Act to require States to annually report on certain adult health quality measures, and for other purposes, all provisions
H.R. 5684, Protecting Seniors From Opioid Abuse Act, all provisions
H.R. 5776, Medicare and Opioid Safe Treatment (MOST) Act, all provisions
H.R. 5789, To amend title XIX of the Social Security Act to provide for Medicaid coverage protections for pregnant and post-partum women while receiving inpatient treatment for a substance use disorder, and for other purposes, all provisions
H.R. 5810, Medicaid Health Homes for Opioid-Use-Disorder Medicaid Enrollees Encouraged (HOME) Act, all provisions
H.R. 5716, Commit to Opioid Medical Prescriber Accountability and Safety for Seniors (COMPASS) Act, all provisions
H.R. 5773, Preventing Addiction for Susceptible Seniors (PASS) Act of 2018, all provisions
H.R. 5775, Providing Reliable Options for Patients and Educational Resources (PROPER) Act of 2018, all provisions
H.R. 5798, Opioid Screening and Chronic Pain Management Alternatives for Seniors Act, all provisions
H.R. 5686, Medicare Clear Health Options in Care for Enrollees (CHOICE) Act of 2018, all provisions
H.R. 6138, Ambulatory Surgical Center (ASC) Payment Transparency Act of 2018, all provisions
H.R. 5774, Combating Opioid Abuse for Care in Hospitals (COACH) Act of 2018, all provisions
H.R. 4206, Medicare Care Coordination Improvement Act of 2017, all provisions
S. 2051, Medicare Care Coordination Improvement Act of 2017, all provisions
H.R. 4143, Dialysis Patient Access To Integrated-care, Empowerment, Nephrologists, Treatment, and Services (PATIENTS) Demonstration Act of 2017, all provisions
H.R. 4554, Medicare Common Access Card Act of 2017, all provisions
H.R. 2788, Health Equity and Access under the Law (HEAL) for Immigrant Women and Families Act of 2017, all provisions
H.R. 2687, Medicaid Coverage for Addiction Recovery Expansion Act, all provisions
S. 1169, Medicaid Coverage for Addiction Recovery Expansion Act, all provisions
S. 1291, Advancing Medical Resident Training in Community Hospitals Act of 2017, all provisions
Medicare program: Draft legislation relating to the prescribing of opioids for individuals eligible for Medicare Part A & B
Medicare program: Creating Access to Residency Education Act (draft bill)
Medicare program: Medicare Access and Chip Reauthorization (MACRA) implementation
Medicare program: Quality Payment Program
Medicare program: Merit-Based Incentive Payment System (MIPS)/quality, cost, interoperability, improvement activities
Medicare program: MIPS quality measure reporting period
Medicare program: Protecting Access to Medicare Act (PAMA)/clinical testing reimbursement
Medicare program: Alternative Payment Models (APMs)
Medicare program: APMs/PTAC
Medicare program: Medicare Shared Savings Program
Medicare program: Graduate Medical Education (GME)
Medicare program: Electronic prescribing of controlled substances
Medicare program: Regulatory Relief
Medicare program: Self-referral
Medicare program: Anti-kickback
Medicare program: Program Integrity - Recovery Audit Contractors (RACs)
Medicare program: Regulatory Relief - E & M Guidelines
Medicare program: Virtual Diabetes Prevention Program (DPP)/Telehealth/remote patient monitoring
Medicare program: Drug pricing transparency
Medicare program: Coding
Medicare program: Prior authorization
Medicare program: Documentation errors
Medicare program: Health Information Technology burdens
Medicare program: Cybersecurity
Medicare program: Interoperability
Medicare program: Group Purchasing Organizations/Stark Laws
Medicare program: Substance abuse disorder/quality, research
Medicare program: Electronic payments
Medicare program: Electronic clinical attachments
Medicare program: Ambulatory blood pressure monitoring
Medicare program: Physician billing/MACs
Medicare program: Open Payments
Medicare program: PECOS/Medicare Enrollment/Revocations/Revalidations
Medicare program: Medicare Diabetes Prevention Program
Medicare program: Misvalued codes
Medicare program: Pharmacy Benefits Manager
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Government Accountability Office (GAO), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Ashley |
McGlone |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
FDA Tobacco regulatory authority
Nicotine level in cigarettes
Large and premium cigars - FDA regulation
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 1876, Good Samaritan Health Professionals Act of 2017, all provisions
S. 781, Good Samaritan Health Professionals Act of 2017, all provisions
S. 2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018, provision related to liability
S. 808, Sports Medicine Licensure Clarity Act of 2017, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Dana |
Lichtenberg |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
H.R. 5674, VA Maintaining Internal Systems and Strengthening Integrated Outside Networks (VA MISSION) Act of 2018, all provisions
S. 2906, VA Maintaining Internal Systems and Strengthening Integrated Outside Networks (VA MISSION) Act of 2018, all provisions
VA Choice Program
Transgender policy
Scope of Practice
Tricare
VAs Anywhere to Anywhere Initiative (Telehealth)
17. House(s) of Congress and Federal agencies Check if None
Veterans Affairs - Dept of (VA), Defense - Dept of (DOD), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |